DGAP-News: Pacific Biosciences' Software Upgrade Enhances De Novo Genome Assembly, Variant Calling and cDNA Transcript Analysis
(firmenpresse) - Pacific Biosciences of California, Inc.
29.01.2013 13:30
---------------------------------------------------------------------------
MENLO PARK, Calif., 2013-01-29 13:30 CET (GLOBE NEWSWIRE) --
Pacific Biosciences of California, Inc. (Nasdaq:PACB) provider of the PacBio(r)
RS High Resolution Genetic Analyzer, today announced it is releasing a new
software upgrade that provides higher quality genome assemblies with near
perfect base level accuracy in addition to other key features. The software
upgrade extends the range of projects that uniquely benefit from the company's
Single Molecule, Real-Time (SMRT(r)) DNA Sequencing method, and will be available
to customers for download on January 31st.
SMRT Analysis 1.4 includes a new hierarchical de novo genome assembly process
(HGAP), which allows researchers to assemble entire microbial and fungal
genomes solely using PacBio long reads. As a result, users can generate better
assemblies with a single library preparation and fewer SMRT(r) Cells than
previous approaches that also required short-read sequencing technologies or
circular consensus sequencing.
SMRT Analysis 1.4 also incorporates a new multi-read consensus algorithm called
Quiver to determine the finished genome sequence with exceptional accuracy.
Quiver can provide greater than 99.999% consensus accuracy for both
resequencing and de novo assembly applications.
'The extra-long sequence reads and the subsequent highly accurate de novo
assemblies produced by the PacBio RS through the latest software enhancements
have immensely improved our ability to discover and understand novel genomes
cost-effectively,' said J. Craig Venter, Ph.D., Founder, Chairman, and Chief
Executive Officer at The J. Craig Venter Institute and CEO of Synthetic
Genomics.
The software upgrade also includes support for analyzing full-length cDNA
transcripts, facilitating understanding of transcription, gene structure and
alternative splicing. Unlike any other sequencing technology, SMRT Sequencing
can span entire cDNA transcripts with a single read, revealing the complete
exonic structure of transcripts.
Additional features of the new SMRT Analysis 1.4 upgrade include:
-- Support for analysis of barcoded samples;
-- Improvements to the tools for analyzing and visualizing bacterial
methylomes, a capability unique to SMRT Sequencing;
-- Enhanced user and group permissions to help sequencing centers and core
labs control what data is presented to end users.
'We are committed to continually improving the performance of the PacBio RS, in
part through developing software enhancements designed to leverage the unique
characteristics of our system,' said Kevin Corcoran, Senior Vice President of
Market Development at Pacific Biosciences. 'With long sequence reads, gold
standard accuracy and higher quality assemblies, the genomics community can
enjoy the benefits of truly finished genomes through SMRT Sequencing.'
The new SMRT Analysis software upgrade is available for download from Pacific
Biosciences' community website, along with sample data and protocols for cDNA
sample preparation and barcoding. To access the software, data, and
documentation, visit www.smrtcommunity.com.
For more information on the new SMRT Analysis software and the PacBio RS High
Resolution Genetic Analyzer,please visit www.pacificbiosciences.com.
About Pacific Biosciences
Pacific Biosciences of California, Inc. (Nasdaq:PACB) offers the PacBio(r) RS
High Resolution Genetic Analyzer to help scientists solve genetically complex
problems. Based on its novel Single Molecule, Real-Time (SMRT(r)) technology,
the company's products enable: targeted sequencing to more comprehensively
characterize genetic variations; de novo genome assembly to more fully
identify, annotate and decipher genomic structures; and DNA base modification
identification to help characterize epigenetic regulation and DNA damage. By
providing access to information that was previously inaccessible, Pacific
Biosciences enables scientists to increase their understanding of biological
systems.
CONTACT: Media:
Maurissa Messier
For Pacific Biosciences
760.539.7417
maurissa(at)bioscribe.com
Investors:
Trevin Rard
Pacific Biosciences
650.521.8450
ir(at)pacificbiosciences.com
News Source: NASDAQ OMX
29.01.2013 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Pacific Biosciences of California, Inc.
United States
Phone:
Fax:
E-mail:
Internet:
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Themen in dieser Pressemitteilung:
pacific-biosciences-software-upgrade-enhances-de-novo-genome-assembly
variant-calling-and-cdna-transcript-analysis
Unternehmensinformation / Kurzprofil:
Datum: 29.01.2013 - 13:30 Uhr
Sprache: Deutsch
News-ID 223816
Anzahl Zeichen: 4013
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 231 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Pacific Biosciences' Software Upgrade Enhances De Novo Genome Assembly, Variant Calling and cDNA Transcript Analysis"
steht unter der journalistisch-redaktionellen Verantwortung von
Pacific Biosciences of California, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
